BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Keros Therapeutics\, Inc. (KROS) investor events
X-WR-CALNAME:Keros Therapeutics\, Inc. (KROS) investor events
DESCRIPTION:Earnings calls and investor events for Keros Therapeutics\, Inc
 . (KROS)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Keros Therapeutics\, In
 c. (KROS)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:a1478e71-1900-4276-8f62-4d041b572b83@equibles.com
DTSTAMP:20260702T134636Z
DTSTART:20260225T162000Z
DTEND:20260225T172000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Conference: Oppenheimer 36th Annua
 l Healthcare Life Sciences Conference
DESCRIPTION:Oppenheimer 36th Annual Healthcare Life Sciences Conference\nWe
 bcast: https://event.summitcast.com/view/CTtthLh2Bi2D9aYoKpvtEv/V8otRzLTXb
 58JhbhcNWND2
END:VEVENT
BEGIN:VEVENT
UID:e03ab745-2e23-484d-831b-dc8ff22d6c87@equibles.com
DTSTAMP:20260702T134636Z
DTSTART:20260303T145000Z
DTEND:20260303T155000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Conference: TD Cowen 46th Annual H
 ealth Care Conference
DESCRIPTION:TD Cowen 46th Annual Health Care Conference\nWebcast: https://e
 vent.summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/gAsAzarzXsTWnurjwhWYFM
END:VEVENT
BEGIN:VEVENT
UID:648fed79-08e5-4e7f-8973-55e3dca4e454@equibles.com
DTSTAMP:20260704T022113Z
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260305
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:c1b83240-dded-4037-ae44-8c8a382d654d@equibles.com
DTSTAMP:20260702T134636Z
DTSTART:20260310T170000Z
DTEND:20260310T180000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Conference: Leerink Partners Globa
 l Healthcare Conference
DESCRIPTION:Leerink Partners Global Healthcare Conference\nWebcast: https:/
 /event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/4HAHET37grTuDD8oiMF2x7
END:VEVENT
BEGIN:VEVENT
UID:cc49c250-d5f4-49af-85af-e30945525bf8@equibles.com
DTSTAMP:20260617T191047Z
DTSTART;VALUE=DATE:20260514
DTEND;VALUE=DATE:20260515
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:ddf52726-4f52-4900-aa29-1c399b6cee0c@equibles.com
DTSTAMP:20260624T233126Z
DTSTART;VALUE=DATE:20260608
DTEND;VALUE=DATE:20260609
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Keros Therapeutics\, Inc. (KROS) Conference: Goldman Sachs 47th Ann
 ual Global Healthcare Conference
DESCRIPTION:Goldman Sachs 47th Annual Global Healthcare Conference\nThe sta
 rt time has not been announced.\nWebcast: https://event.webcasts.com/start
 here.jsp?ei=1765816&tp_key=355ecc75fe&tp_special=8
URL:https://equibles.com/stocks/kros/events/ddf52726-4f52-4900-aa29-1c399b6
 cee0c
END:VEVENT
END:VCALENDAR